Adria Lopez-Fernandez
Overview
Explore the profile of Adria Lopez-Fernandez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
374
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Monteagudo M, Calsina B, Salazar-Hidalgo M, Martinez-Montes A, Pineiro-Yanez E, Caleiras E, et al.
Best Pract Res Clin Endocrinol Metab
. 2024 Sep;
38(6):101931.
PMID: 39218714
Pheochromocytomas and paragangliomas are rare neuroendocrine tumours. Around 20-25 % of patients develop metastases, for which there is an urgent need of prognostic markers and therapeutic stratification strategies. The presence...
2.
Sanchez-Heras A, Damaso E, Castillejo A, Robledo M, Teule A, Lazaro C, et al.
Orphanet J Rare Dis
. 2024 Jan;
19(1):26.
PMID: 38279137
Background: Hereditary leiomyomatosis and renal cell cancer syndrome is a rare autosomal dominant hereditary syndrome. Previously, we published the largest cohort of FH mutation carriers in Spain and observed a...
3.
Calsina B, Pineiro-Yanez E, Martinez-Montes A, Caleiras E, Fernandez-Sanroman A, Monteagudo M, et al.
Nat Commun
. 2023 Feb;
14(1):1122.
PMID: 36854674
The mechanisms triggering metastasis in pheochromocytoma/paraganglioma are unknown, hindering therapeutic options for patients with metastatic tumors (mPPGL). Herein we show by genomic profiling of a large cohort of mPPGLs that...
4.
Mellid S, Gil E, Leton R, Caleiras E, Honrado E, Richter S, et al.
Front Endocrinol (Lausanne)
. 2023 Feb;
13:1070074.
PMID: 36760809
Introduction: The percentage of patients diagnosed with pheochromocytoma and paraganglioma (altogether PPGL) carrying known germline mutations in one of the over fifteen susceptibility genes identified to date has dramatically increased...
5.
Lopez-Fernandez A, Villacampa G, Salinas M, Grau E, Darder E, Carrasco E, et al.
J Genet Couns
. 2023 Feb;
32(4):778-787.
PMID: 36748747
Clinical and familial factors predict psychological distress after genetic testing for cancer susceptibility. However, the contribution of an individual's psychological background to such distress is unclear. This study aims to...
6.
Carrasco E, Lopez-Fernandez A, Codina-Sola M, Valenzuela I, Cueto-Gonzalez A, Villacampa G, et al.
J Med Genet
. 2022 Nov;
60(7):685-691.
PMID: 36446584
Background/objectives: Exome sequencing may identify pathogenic variants unrelated with the purpose of the analysis. We investigated the frequency of secondary and incidental findings (SF/IF) in cancer susceptibility genes (CSG), their...
7.
Marmolejo Castaneda D, Cruellas Lapena M, Carrasco Lopez E, Espanol G, Valverde Morales C, Lopez-Fernandez A, et al.
Fam Cancer
. 2022 Jul;
22(1):99-102.
PMID: 35781852
Rothmund-Thomson syndrome, a heterogeneous genodermatosis with autosomal recessive hereditary pattern, is an uncommon cancer susceptibility genetic syndrome. To date, only 400 cases have been reported in the literature, and the...
8.
Tamborero D, Dienstmann R, Rachid M, Boekel J, Lopez-Fernandez A, Jonsson M, et al.
Nat Cancer
. 2022 Apr;
3(5):649.
PMID: 35449310
No abstract available.
9.
Tamborero D, Dienstmann R, Rachid M, Boekel J, Lopez-Fernandez A, Jonsson M, et al.
Nat Cancer
. 2022 Feb;
3(2):251-261.
PMID: 35221333
There is a growing need for systems that efficiently support the work of medical teams at the precision-oncology point of care. Here, we present the implementation of the Molecular Tumor...
10.
Barnes D, Silvestri V, Leslie G, McGuffog L, Dennis J, Yang X, et al.
J Natl Cancer Inst
. 2021 Jul;
114(1):109-122.
PMID: 34320204
Background: Recent population-based female breast cancer and prostate cancer polygenic risk scores (PRS) have been developed. We assessed the associations of these PRS with breast and prostate cancer risks for...